On Aug. 10, 2021, Moderna announced a Memorandum of Understanding (MoU) with the government of Canada to build a state-of-the-art messenger RNA (mRNA) vaccine manufacturing facility in Canada including access to Modernaﾒs mRNA development engine.

The goals of this MoU are to build the foundation to support Canada with direct access to rapid pandemic response capabilities and to provide access to Modernaﾒs vaccines in development for respiratory viruses.